Phase II Proof of Concept Trial to Determine Efficacy of Fexinidazole in Visceral Leishmaniasis Patients in Sudan
Phase of Trial: Phase II
Latest Information Update: 21 Sep 2015
Price : $35 *
At a glance
- Drugs Fexinidazole (Primary)
- Indications Visceral leishmaniasis
- Focus Proof of concept; Therapeutic Use
- 17 Sep 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 25 Nov 2013 New trial record
- 12 Nov 2013 Status changed from not yet recruiting to recruiting.